Showing results (351-360 of 494) with videos related to
Sort By:
Pageof 50
Human Pathology|January 23, 2024
A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary glandAlireza Salem, Yun Wu, Constance T Albarracin, et al.Breast Cancer Research and Treatment|March 27, 2013
Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancerJames L Murray, Patricia Thompson, Suk Young Yoo, et al.JAMA Oncology|March 18, 2016
The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After TreatmentElizabeth A Mittendorf, Jose Vila, Susan L Tucker, et al.Pathology Oncology Research : POR|November 3, 2001
Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistryF J Esteva, G N Hortobagyi, A A Sahin, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 19, 2011
The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter studyHasmet A Hanagasi, Hakan Gurvit, Pınar Unsalan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancerN Cabioglu, Y Gong, R Islam, et al.Annals of Surgical Oncology|September 19, 2013
Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patientsAbigail S Caudle, Min Yi, Karen E Hoffman, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breastHenry M Kuerer, George E Peoples, Aysegul A Sahin, et al.Journal for Immunotherapy of Cancer|March 16, 2021
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cellsStanley Ly, Vivek Anand, Fouad El-Dana, et al.Cancer|October 20, 2011
Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancerYun Wu, Elizabeth A Mittendorf, Canan Kelten, et al.Pageof 50